Candriam Sustainable Equity Europe R

Reference Data

ISIN LU1720118618
Valor Number
Bloomberg Global ID
Fund Name Candriam Sustainable Equity Europe R
Fund Provider CANDRIAM Serenity, Bloc - B, 19-21, route d'Arlon
8009 Strassen
E-Mail: CH@Candriam.com
Phone: + 352 2797-1
Web: https://www.candriam.com
Fund Provider CANDRIAM
Representative in Switzerland CACEIS (Switzerland) SA
Nyon
Phone: +41 22 360 94 00
Distributor(s)
Asset Class Equities
EFC Category
Distribution Policy Distribution
Home Country Luxembourg
Issuing Condition Combination of issuing commission charged by the fund management company and transaction fee charged by the fund
Redemption Condition Combination of redemption commission charged by the fund management company and transaction fee charged by the fund
Investment Strategy *** The aim of the Sub-Fund is to enable shareholders to benefit from the growth of the European equity markets with an investment in equities selected by the portfolio management team on a discretionary basis and to outperform the benchmark. The selection is based on the stocks characteristics and growth prospects, as well as proprietary analysis of ESG criteria.
Peculiarities

Fund Prices

Current Price * 103.81 EUR 18.09.2024
Previous Price * 104.24 EUR 17.09.2024
52 Week High * 105.90 EUR 30.08.2024
52 Week Low * 88.56 EUR 27.10.2023
NAV * 103.81 EUR 18.09.2024
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 934,298,425
Unit/Share Assets *** 1,270,793
Trading Information SIX

Performance

YTD Performance +3.29% 29.12.2023
18.09.2024
YTD Performance (in CHF) +4.63% 29.12.2023
18.09.2024
1 month +0.62% 19.08.2024
18.09.2024
3 months +0.95% 18.06.2024
18.09.2024
6 months -0.45% 18.03.2024
18.09.2024
1 year +7.80% 18.09.2023
18.09.2024
2 years +13.33% 19.09.2022
18.09.2024
3 years -1.61% 23.09.2021
18.09.2024
5 years - -

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Novo Nordisk A/S Class B 4.22%
ASML Holding NV 3.97%
KBC Groupe NV 3.94%
Nestle SA 3.91%
Novartis AG Registered Shares 3.07%
Roche Holding AG 2.88%
AstraZeneca PLC 2.81%
FinecoBank SpA 2.77%
Dassault Systemes SE 2.73%
Unilever PLC 2.70%
Last data update 30.06.2024

Cost / Risk

TER 1.02%
TER date 31.12.2021
Performance Fee ***
PTR
Max. Management Fee *** 0.80%
Ongoing Charges *** 1.00%
SRRI ***
SRRI date *** 31.08.2024

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 *** GMOs

* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)